Abstract:Vitamin D deficiency is considered a pandemic and has been postulated to increase the risk of type 2 diabetes mellitus (T2DM). Activation of nod-like receptor protein 3 (NLRP3) signaling induced by hyperglycemia stress has been recognized as a key priming stage for pancreatic β-cell inflammation in T2DM pathogenesis. AMP-activated protein kinase (AMPK) activation attenuates NLRP3 inflammasome upregulation in diabetes. This study investigated whether vitamin D3 could protect cells against high glucose-induced inflammation by modulating this critical step. A human cross-sectional study of 78 healthy, glucose-tolerant volunteers and 399 patients with type 2 diabetes was undertaken. The relationship between serum 25(OH)D3 levels and β-cell function was assessed using Pearson correlation analysis and multiple linear regression, and a high-glucose diet-induced rat model of impaired glucose tolerance was used to evaluate the effects of cholecalciferol. Intraperitoneal glucose tolerance tests and an ELISA were performed to detect the function of pancreatic islets. Glucose-stimulated insulin secretion, pyroptosis, reactive oxygen species (ROS) production, and NLRP3 pathway were evaluated together to determine the role of vitamin D in high glucose-induced pancreatic β-cell dysfunction in INS-1E cells. The clinical results showed a positive association between serum 25(OH)D3 levels and β-cell function in male patients with type 2 diabetes. In vivo, cholecalciferol significantly reduced blood glucose levels and improved insulin secretion in response to glucose loading in the high glucose diet-induced rat model. In vitro studies have demonstrated that 1,25(OH)<sub>2</sub>D3 promotes insulin release in both islets and INS-1E cells. Mechanistically, our results demonstrated that vitamin D3 can activate AMPK, inhibiting the mTOR pathway, thus inhibiting NLRP3 inflammasome activation and alleviating pyroptosis in β-cell dysfunction. This study showed that vitamin D protects against high-glucose-induced β-cell dysfunction by enhancing the AMPK pathway, thereby suppressing NLRP3 inflammasome activation.

Vanadyl Bisacetylacetonate Protects Β Cells from Palmitate-Induced Cell Death Through the Unfolded Protein Response Pathway.

Vanadyl Acetylacetonate Upregulates PPARγ and Adiponectin Expression in Differentiated Rat Adipocytes

Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.

Vanadium Compounds Modulate PPARγ Activity Primarily by Increasing PPARγ Protein Levels in Mouse Insulinoma NIT-1 Cells

Is the Hypoglycemic Action of Vanadium Compounds Related to the Suppression of Feeding?

DGAT1 inhibitors protect pancreatic β-cells from palmitic acid-induced apoptosis

Vitamin D Switches BAF Complexes to Protect β Cells

Synthesis And Anti-Diabetic Activity Of New N,N-Dimethylphenylenediamine-Derivatized Nitrilotriacetic Acid Vanadyl Complexes

Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress.

Vanadium stimulates mitochondrial ROS production in different ways

The Molecular Mechanisms and Rational Design of Anti-Diabetic Vanadium Compounds.

Vanadium-protein complex inhibits human adipocyte differentiation through the activation of β-catenin and LKB1/AMPK signaling pathway

Pharmacodynamics and Pharmacokinetics of the Insulin-Mimetic Agent Vanadyl Acetylacetonate in Non-Diabetic and Diabetic Rats.

Isosteviol Has Beneficial Effects On Palmitate-Induced Alpha-Cell Dysfunction And Gene Expression

Effects on the Bones of Vanadyl Acetylacetonate by Oral Administration: a Comparison Study in Diabetic Rats.

Anti-diabetic Vanadyl Complexes Reduced Alzheimer’s Disease Pathology Independent of Amyloid Plaque Deposition

Effective Control of Blood Glucose Status and Toxicity in Streptozotocin-Induced Diabetic Rats by Orally Administration of Vanadate in an Herbal Decoction

Vanadium compounds: New potential antidiabetic drugs

Vitamin D protects against high glucose-induced pancreatic β-cell dysfunction via AMPK-NLRP3 inflammasome pathway

Antioxidation of a proteoglycan from Ganoderma lucidum protects pancreatic β-cells against oxidative stress-induced apoptosis in vitro and in vivo

Vanadyl ions binding to GroEL (HSP60) and inducing its depolymerization